A few thousand years ago, we were the largest shareholder in Tripos, an early attempt at pre-AI drug discovery tooling. We made a lot of money in Simulations Plus before it was “discovered.” We own Certara now.
This is an interesting piece on how it’s not so easy to change the world with AI, despite how desperately cool the headlines look.
Drug Discovery Has No Magic Wands
On AI, human biology, and what it will actually take to discover transformative new medicines
The tech world has latched onto an intoxicating promise: build a superintelligence, and it will cure cancer, and every other disease as well. The logic is seductive. The human body is a system we can already read from and write to, so like other knowledge problems, a powerful enough AI should be able to solve disease.
I fully believe that AI will eventually transform human health. It is why I’ve spent close to 30 years working at the intersection of AI and biology, and the last decade in drug discovery. The need is staggering: by most counts only a quarter of diseases — and by some estimates a few percent — have an approved therapy, and most of those merely slow a disease rather than stop it. For the majority of human illness, medicine still has little to offer.
But the magic-wand promise rests on… Read the full article at Deep Phenotype.
